Dissecting the Gene Dose-Effects of the APOE ε4 and ε2 Alleles on Hippocampal Volumes in Aging and Alzheimer’s Disease

Objective To investigate whether there is a specific dose-dependent effect of the Apolipoprotein E (APOE) ε4 and ε2 alleles on hippocampal volume, across the cognitive spectrum, from normal aging to Alzheimer’s Disease (AD). Materials and Methods We analyzed MR and genetic data on 662 patients from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database–198 cognitively normal controls (CN), 321 mild-cognitive impairment (MCI) subjects, and 143 AD subjects–looking for dose-dependent effects of the ε4 and ε2 alleles on hippocampal volumes. Volumes were measured using a fully-automated algorithm applied to high resolution T1-weighted MR images. Statistical analysis consisted of a multivariate regression with repeated-measures model. Results There was a dose-dependent effect of the ε4 allele on hippocampal volume in AD (p = 0.04) and MCI (p = 0.02)–in both cases, each allele accounted for loss of >150 mm3 (approximately 4%) of hippocampal volume below the mean volume for AD and MCI subjects with no such alleles (Cohen’s d = −0.16 and −0.19 for AD and MCI, respectively). There was also a dose-dependent, main effect of the ε2 allele (p<0.0001), suggestive of a moderate protective effect on hippocampal volume–an approximately 20% per allele volume increase as compared to CN with no ε2 alleles (Cohen’s d = 0.23). Conclusion Though no effect of ε4 was seen in CN subjects, our findings confirm and extend prior data on the opposing effects of the APOE ε4 and ε2 alleles on hippocampal morphology across the spectrum of cognitive aging.

[1]  A. Toga,et al.  Detection and mapping of abnormal brain structure with a probabilistic atlas of cortical surfaces. , 1997, Journal of computer assisted tomography.

[2]  I G McKeith,et al.  MRI volumetric study of dementia with Lewy bodies , 2000, Neurology.

[3]  A. Dale,et al.  Improved Localizadon of Cortical Activity by Combining EEG and MEG with MRI Cortical Surface Reconstruction: A Linear Approach , 1993, Journal of Cognitive Neuroscience.

[4]  Magda Tsolaki,et al.  Effect of APOE ε4 allele on cortical thicknesses and volumes: the AddNeuroMed study. , 2010, Journal of Alzheimer's disease : JAD.

[5]  M. Pericak-Vance,et al.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Kaarin J Anstey,et al.  Total and regional gray matter volume is not related to APOE*E4 status in a community sample of middle-aged individuals. , 2008, The journals of gerontology. Series A, Biological sciences and medical sciences.

[7]  Anders M. Dale,et al.  Nonlinear registration of longitudinal images and measurement of change in regions of interest , 2011, Medical Image Anal..

[8]  Bruce Fischl,et al.  Geometrically Accurate Topology-Correction of Cortical Surfaces Using Nonseparating Loops , 2007, IEEE Transactions on Medical Imaging.

[9]  Anders M. Dale,et al.  Reliability of MRI-derived measurements of human cerebral cortical thickness: The effects of field strength, scanner upgrade and manufacturer , 2006, NeuroImage.

[10]  H C Charles,et al.  Impact of APOE in mild cognitive impairment , 2004, Neurology.

[11]  Carole Dufouil,et al.  No epsilon4 gene dose effect on hippocampal atrophy in a large MRI database of healthy elderly subjects. , 2005, NeuroImage.

[12]  E G Tangalos,et al.  Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease , 1998, Annals of neurology.

[13]  Anders M. Dale,et al.  Improved Localization of Cortical Activity By Combining EEG and MEG with MRI Cortical Surface Reconstruction , 2002 .

[14]  Christopher H. van Dyck,et al.  Apolipoprotein E epsilon4 is associated with atrophy of the amygdala in Alzheimer's disease , 2000, Neurobiology of Aging.

[15]  J A Edwardson,et al.  Protective effect of apoE epsilon 2 in Alzheimer's disease. , 1994, Lancet.

[16]  Carole Dufouil,et al.  Effects of ApoE-ɛ4 allele load and age on the rates of grey matter and hippocampal volumes loss in a longitudinal cohort of 1186 healthy elderly persons , 2010, NeuroImage.

[17]  E. Bjertness,et al.  Protective effect of apoE ∈2 in Alzheimer's disease , 1994, The Lancet.

[18]  Anders M. Dale,et al.  Automated manifold surgery: constructing geometrically accurate and topologically correct models of the human cerebral cortex , 2001, IEEE Transactions on Medical Imaging.

[19]  C. Solé-Padullés,et al.  Apolipoproteins E and C1 and brain morphology in memory impaired elders , 2003, Neurogenetics.

[20]  D. Holtzman,et al.  ApoE Promotes the Proteolytic Degradation of Aβ , 2008, Neuron.

[21]  James R. MacFall,et al.  Predicting memory decline in normal elderly: Genetics, MRI, and cognitive reserve , 2007, Neurobiology of Aging.

[22]  Norbert Schuff,et al.  Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls , 2009, NeuroImage.

[23]  Anders M. Dale,et al.  Cortical Surface-Based Analysis I. Segmentation and Surface Reconstruction , 1999, NeuroImage.

[24]  A M Dale,et al.  Measuring the thickness of the human cerebral cortex from magnetic resonance images. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[25]  C. Jack,et al.  MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers , 2008, Brain : a journal of neurology.

[26]  M Schwaiger,et al.  Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease , 2009, Neurology.

[27]  R. Mahley,et al.  Apolipoprotein E: far more than a lipid transport protein. , 2000, Annual review of genomics and human genetics.

[28]  B. Hyman,et al.  Frequency of the apolipoprotein E ε2 allele is diminished in sporadic Alzheimer disease , 1994, Neuroscience Letters.

[29]  Thomas E. Nichols,et al.  Anatomically-distinct genetic associations of APOE ɛ4 allele load with regional cortical atrophy in Alzheimer's disease , 2009, NeuroImage.

[30]  M. Kindy,et al.  Apolipoprotein E and Alzheimer's disease: the protective effects of ApoE2 and E3. , 2002, Journal of Alzheimer's disease : JAD.

[31]  Carole Dufouil,et al.  No ɛ4 gene dose effect on hippocampal atrophy in a large MRI database of healthy elderly subjects , 2005, NeuroImage.

[32]  Alan C. Evans,et al.  APOE ε2 Allele Is Associated with Larger Regional Cortical Thicknesses and Volumes , 2010, Dementia and Geriatric Cognitive Disorders.

[33]  Alan C. Evans,et al.  A nonparametric method for automatic correction of intensity nonuniformity in MRI data , 1998, IEEE Transactions on Medical Imaging.

[34]  D. Selkoe.  Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[35]  M. Farlow.  Alzheimer's disease: Clinical implications of the apolipoprotein E genotype , 1997, Neurology.

[36]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[37]  Paul M. Thompson,et al.  Reduced cortical thickness in hippocampal subregions among cognitively normal apolipoprotein E e4 carriers , 2008, NeuroImage.

[38]  A. Smith,et al.  Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease , 1995, Neuroscience.

[39]  A Hofman,et al.  Hippocampal, amygdalar, and global brain atrophy in different apolipoprotein E genotypes , 2002, Neurology.

[40]  A. Dale,et al.  Unbiased comparison of sample size estimates from longitudinal structural measures in ADNI , 2012, Human brain mapping.

[41]  Anders M. Dale,et al.  A hybrid approach to the Skull Stripping problem in MRI , 2001, NeuroImage.

[42]  C R Jack,et al.  Hippocampal atrophy rates and CSF biomarkers in elderly APOE2 normal subjects , 2010, Neurology.

[43]  Nick C Fox,et al.  The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods , 2008, Journal of magnetic resonance imaging : JMRI.

[44]  B. Teter,et al.  The presence of apoE4, not the absence of apoE3, contributes to AD pathology. , 2002, Journal of Alzheimer's disease : JAD.

[45]  C. Jack,et al.  Alzheimer's Disease Neuroimaging Initiative , 2008 .

[46]  B. Hyman,et al.  Frequency of the apolipoprotein E epsilon 2 allele is diminished in sporadic Alzheimer disease. , 1994, Neuroscience letters.